Gene · 10371
Papers3,028
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,028
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Persistent Inflammation in the Pathogenesis of Infected Nonunion: A Narrative Review. | Immun Inflamm Dis | 2025 | 40955781 | PubTator, text mining | PubMed |
| Exploring the Prognostic Role of Neurofilaments and SEMA3A in Multiple Sclerosis Progression. | Int J Mol Sci | 2025 | 40943667 | PubTator, text mining | PubMed |
| HIC2 suppresses glioblastoma progression via transcriptional repression of SEMA3A and inhibition of TGF-β signaling. | Free Radic Biol Med | 2025 | 40921301 | PubTator, text mining | PubMed |
| Neuropilin-1 expression in primary and metastatic prostate cancer: Expression patterns and clinicopathological correlations. | Mol Clin Oncol | 2025 | 40900735 | PubTator, text mining | PubMed |
| Bridging the gap of late-gestation nephrogenesis using a non-human primate model. | bioRxiv | 2025 | 40894529 | PubTator, text mining | PubMed |
| Human iPSCs-derived mesenchymal stem cells promote skin regeneration and burn wound healing. | NPJ Regen Med | 2025 | 40885782 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Steatotic Liver Disease Shapes a Distinct Semaphorin-Cytokine Immune Signature in Severe Community-Acquired Pneumonia. | Int J Mol Sci | 2025 | 40869413 | PubTator, text mining | PubMed |
| Tailoring Inflammatory Biomarker Assessment in Axial Spondyloarthritis: A Comparative Study of Erythrocyte Sedimentation Rate and C-Reactive Protein Across Disease Profiles. | J Pers Med | 2025 | 40863391 | PubTator, text mining | PubMed |
| Intra-articular hexagonal boron nitride-hyaluronic acid composite hydrogels rebalance cytokine profiles and enhance extracellular matrix regeneration in a rabbit osteoarthritis model. | Inflammopharmacology | 2025 | 40820067 | PubTator, text mining | PubMed |
| Comprehensive analysis of the PLXNA3 gene on prognosis and immune characteristics in breast cancer. | Sci Rep | 2025 | 40760011 | PubTator, text mining | PubMed |
| Semaphorin-3A in autoimmune rheumatic diseases: immunological and pathological aspects. | Inflammopharmacology | 2025 | 40759850 | PubTator, text mining | PubMed |
| Genome-Wide 5-Methylcytosine and 5-Hydroxymethylcytosine Signatures Analysis of Plasma Cell-Free DNA in Schizophrenia. | MedComm (2020) | 2025 | 40740482 | PubTator, text mining | PubMed |
| Magnetic nanoparticles influence the biological function of mesenchymal stem cells. | Sci Rep | 2025 | 40739120 | PubTator, text mining | PubMed |
| Osteocytes function as biomechanical signaling hubs bridging mechanical stress sensing and systemic adaptation. | Front Physiol | 2025 | 40735673 | PubTator, text mining | PubMed |
| Feedback-Driven Dynamical Model for Axonal Extension on Parallel Micropatterns. | Biomimetics (Basel) | 2025 | 40710269 | PubTator, text mining | PubMed |
| Pharmacological effects and mechanism of Maxing Shigan Decoction in the treatment of influenza A viral pneumonia. | J Ethnopharmacol | 2025 | 40659142 | PubTator, text mining | PubMed |
| New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A/Nrp1 pathway. | Eye (Lond) | 2025 | 40634736 | PubTator, text mining | PubMed |
| A unifying mechanism for presynaptic homeostatic plasticity at mammalian peripheral and central synapses. | Neuron | 2025 | 40592327 | PubTator, text mining | PubMed |
| Disruption of Plexin-A1 signaling by FTX-101: mode of action and effect on oligodendrocyte biology. | Biomed Pharmacother | 2025 | 40435840 | PubTator, text mining | PubMed |
| [Molecular genetics in pediatric endocrinology: 35 years of research]. | Probl Endokrinol (Mosk) | 2025 | 40411325 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10371/papers?page=5